No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Another P1/2 NCI Trial
Reply New Message
Back To Forum List View

yes were nothing more than a university research group - so exciting as we drop almosrt 32% to 15 pennies but there 15 US pennies. 

Excellent job Mccrafty 

4 Recommendations
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply